%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Nilmini Chandrasena, Ranjan Premaratna, Indeewarie. E. Gunaratna, Nilanthi R. de Silva
Morbidity management and disability prevention for lymphatic filariasis in Sri Lanka: Current status and future prospects
www.plosntds.org
www.plosntds.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 9 0 R/Annots 10 0 R/Contents 11 0 R/TrimBox[0 0 612 792]>>
endobj
10 0 obj
[12 0 R 13 0 R 14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R]
endobj
12 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref001)>>
endobj
13 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref002)>>
endobj
14 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref003)>>
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref004)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref005)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref006)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref007)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref008)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref009)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref010)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref011)>>
endobj
23 0 obj
<>/Border[0 0 0]/A 24 0 R>>
endobj
24 0 obj
<>
endobj
11 0 obj
[25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R]
endobj
25 0 obj
<>stream
q
0.955 g
0 w
199.9998 641.23 m
575.9997 641.23 l
575.9997 389.2306 l
199.9998 389.2306 l
f*
0.45 0.36 0.35 0.01 k
575.9997 666.2299 m
199.9998 666.2299 l
199.9998 666.7299 l
575.9997 666.7299 l
f*
0.83 0.64 0.02 0 k
398.1543 315.9496 m
402.8598 315.9496 l
h
f*
264.1323 224.9008 m
268.8945 224.9008 l
h
f*
273.3732 224.9008 m
278.1354 224.9008 l
h
f*
282.5575 224.9008 m
287.3197 224.9008 l
h
f*
363.4016 211.9181 m
368.1638 211.9181 l
h
f*
390.1606 185.8961 m
394.9228 185.8961 l
h
f*
399.4016 185.8961 m
404.1638 185.8961 l
h
f*
408.5858 185.8961 m
413.348 185.8961 l
h
f*
417.8268 185.8961 m
422.589 185.8961 l
h
f*
427.011 185.8961 m
436.5354 185.8961 l
h
f*
355.6346 146.948 m
365.1591 146.948 l
h
f*
0 g
1 j
1 J
9.5 0 0 9.5 200.0125 707.7543 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(program)Tj
3.9028 0 Td
(sustainability.)Tj
6.1467 0 Td
(The)Tj
1.9275 0 Td
(identified)Tj
4.1655 0 Td
(opportunities)Tj
5.8721 0 Td
(for)Tj
1.3726 0 Td
(improvement)Tj
5.9438 0 Td
(of)Tj
1.0443 0 Td
(the)Tj
1.5993 0 Td
(programme)Tj
-31.9746 -1.474 Td
(could)Tj
2.578 0 Td
(ensure)Tj
3.2404 0 Td
(better)Tj
2.7511 0 Td
(attainment)Tj
4.8398 0 Td
(of)Tj
1.0443 0 Td
(the)Tj
1.5993 0 Td
(goal)Tj
2.0768 0 Td
(of)Tj
1.0503 0 Td
(the)Tj
1.5934 0 Td
(MMDP)Tj
3.2583 0 Td
(program,)Tj
4.1833 0 Td
(namely)Tj
3.4076 0 Td
(access)Tj
3.306 0 Td
(to)Tj
1.0444 0 Td
(basic)Tj
-35.973 -1.474 Td
(care)Tj
2.1423 0 Td
(for)Tj
1.3786 0 Td
(all)Tj
1.1935 0 Td
(affected)Tj
3.7477 0 Td
(by)Tj
1.2651 0 Td
(lymphatic)Tj
4.3982 0 Td
(filarial)Tj
2.7809 0 Td
(disease.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 209.9905 623.2251 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Author)Tj
3.137 0 Td
(summary)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 209.9905 605.2535 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Lymphatic)Tj
4.4957 0 Td
(filariasis)Tj
3.5092 0 Td
(\(LF\))Tj
1.9616 0 Td
(is)Tj
0.8447 0 Td
(a)Tj
0.6463 0 Td
(tropical)Tj
3.2825 0 Td
(disease)Tj
3.0104 0 Td
(causing)Tj
3.2428 0 Td
(swelling)Tj
3.4526 0 Td
(of)Tj
1.0091 0 Td
(limbs)Tj
2.4151 0 Td
(\(lymphoedema,)Tj
6.4856 0 Td
(ele-)Tj
-34.3556 -1.3039 Td
(phantiasis\))Tj
4.575 0 Td
(and)Tj
1.7348 0 Td
(male)Tj
2.143 0 Td
(genitalia)Tj
3.6 0 Td
(\(hydrocele\).)Tj
5.0343 0 Td
(It)Tj
0.856 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
0.652 0 Td
(disabling)Tj
3.8438 0 Td
(and)Tj
1.7291 0 Td
(deforming)Tj
4.439 0 Td
(disease)Tj
3.016 0 Td
(caused)Tj
-32.4734 -1.2982 Td
(by)Tj
1.1848 0 Td
(parasitic)Tj
3.5887 0 Td
(worms)Tj
2.965 0 Td
(transmitted)Tj
4.8699 0 Td
(by)Tj
1.1792 0 Td
(mosquitoes.)Tj
5.0229 0 Td
(The)Tj
1.7859 0 Td
(Sri)Tj
1.3322 0 Td
(Lankan)Tj
3.2202 0 Td
(Anti)Tj
2.0182 0 Td
(Filariasis)Tj
3.7587 0 Td
(Campaign)Tj
-30.9257 -1.2983 Td
(was)Tj
1.7007 0 Td
(successful)Tj
4.1613 0 Td
(in)Tj
1.0374 0 Td
(reducing)Tj
3.7758 0 Td
(LF)Tj
1.2812 0 Td
(transmission)Tj
5.3688 0 Td
(to)Tj
1.0261 0 Td
(very)Tj
1.9219 0 Td
(low)Tj
1.6554 0 Td
(levels)Tj
2.3754 0 Td
(by)Tj
1.1849 0 Td
(annual)Tj
2.9594 0 Td
(mass)Tj
2.194 0 Td
(drug)Tj
2.1089 0 Td
(admin-)Tj
-32.7512 -1.3039 Td
(istration,)Tj
3.7984 0 Td
(resulting)Tj
3.7303 0 Td
(in)Tj
1.0375 0 Td
(recent)Tj
2.7042 0 Td
(achievement)Tj
5.2668 0 Td
(of)Tj
1.0148 0 Td
(elimination)Tj
4.8472 0 Td
(status.)Tj
2.7269 0 Td
(The)Tj
1.7801 0 Td
(other)Tj
2.3471 0 Td
(pillar)Tj
2.3017 0 Td
(of)Tj
1.0148 0 Td
(LF)Tj
-32.5698 -1.2983 Td
(elimination)Tj
4.8472 0 Td
(is)Tj
0.8504 0 Td
(the)Tj
1.4683 0 Td
(management)Tj
5.4368 0 Td
(of)Tj
1.0148 0 Td
(morbidity)Tj
4.2406 0 Td
(and)Tj
1.7291 0 Td
(disability)Tj
3.8495 0 Td
(prevention)Tj
4.5807 0 Td
(\(MMDP\))Tj
3.9798 0 Td
(among)Tj
-31.9972 -1.2982 Td
(those)Tj
2.3357 0 Td
(with)Tj
2.0012 0 Td
(lymphatic)Tj
4.2066 0 Td
(filarial)Tj
2.7723 0 Td
(disease.)Tj
3.2428 0 Td
(The)Tj
1.7858 0 Td
(strengths,)Tj
4.0989 0 Td
(weaknesses)Tj
4.7395 0 Td
(and)Tj
1.7291 0 Td
(threats)Tj
2.931 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(MMDP)Tj
-32.3317 -1.304 Td
(program)Tj
3.7076 0 Td
(were)Tj
2.1203 0 Td
(evaluated)Tj
3.9912 0 Td
(and)Tj
1.7291 0 Td
(opportunities)Tj
5.6296 0 Td
(for)Tj
1.389 0 Td
(improvement)Tj
5.6692 0 Td
(were)Tj
2.126 0 Td
(explored)Tj
3.702 0 Td
(in)Tj
1.0318 0 Td
(June)Tj
2.0523 0 Td
(2017.)Tj
-33.1481 -1.2982 Td
(The)Tj
1.7858 0 Td
(filariasis)Tj
3.5149 0 Td
(clinics)Tj
2.7553 0 Td
(established)Tj
4.5977 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(endemic)Tj
3.651 0 Td
(area,)Tj
2.109 0 Td
(providing)Tj
4.1499 0 Td
(care)Tj
1.8709 0 Td
(for)Tj
1.3833 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
2.0012 0 Td
(lym-)Tj
-33.6923 -1.2983 Td
(phoedema)Tj
4.3993 0 Td
(and)Tj
1.7348 0 Td
(elephantiasis,)Tj
5.5502 0 Td
(were)Tj
2.126 0 Td
(identified)Tj
4.0591 0 Td
(as)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(main)Tj
2.2904 0 Td
(strength.)Tj
3.736 0 Td
(Hospital)Tj
3.617 0 Td
(surgical)Tj
3.3165 0 Td
(units)Tj
-33.3125 -1.2983 Td
(were)Tj
2.1259 0 Td
(important)Tj
4.2803 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(treatment)Tj
4.1329 0 Td
(of)Tj
1.0148 0 Td
(hydrocele.)Tj
4.354 0 Td
(The)Tj
1.7801 0 Td
(weaknesses)Tj
4.7339 0 Td
(were)Tj
2.1259 0 Td
(low)Tj
1.6555 0 Td
(accessibility)Tj
4.9549 0 Td
(of)Tj
-33.664 -1.3039 Td
(clinics,)Tj
2.982 0 Td
(incomplete)Tj
4.6941 0 Td
(coverage)Tj
3.7247 0 Td
(of)Tj
1.0148 0 Td
(endemic)Tj
3.651 0 Td
(districts,)Tj
3.6227 0 Td
(lack)Tj
1.8198 0 Td
(of)Tj
1.0148 0 Td
(facilities)Tj
3.4979 0 Td
(for)Tj
1.3833 0 Td
(rehabilitation)Tj
5.6183 0 Td
(and)Tj
-33.0234 -1.2982 Td
(lack)Tj
1.8198 0 Td
(of)Tj
1.0148 0 Td
(morbidity)Tj
4.2406 0 Td
(targets.)Tj
3.0954 0 Td
(The)Tj
1.7858 0 Td
(threats)Tj
2.931 0 Td
(were)Tj
2.126 0 Td
(diversion)Tj
3.9458 0 Td
(of)Tj
1.0148 0 Td
(staff)Tj
1.8878 0 Td
(and)Tj
1.7348 0 Td
(resources,)Tj
4.2123 0 Td
(under-utiliza-)Tj
-29.8089 -1.2983 Td
(tion)Tj
1.8425 0 Td
(of)Tj
1.0148 0 Td
(clinics,)Tj
2.982 0 Td
(social)Tj
2.4604 0 Td
(stigma)Tj
2.863 0 Td
(and)Tj
1.7291 0 Td
(loss)Tj
1.6951 0 Td
(of)Tj
1.0148 0 Td
(alliances.)Tj
3.8325 0 Td
(Enhanced)Tj
4.2236 0 Td
(commitment)Tj
5.4424 0 Td
(to)Tj
1.0262 0 Td
(improve)Tj
-30.1264 -1.3039 Td
(coverage)Tj
3.7247 0 Td
(and)Tj
1.7291 0 Td
(access)Tj
2.6475 0 Td
(to)Tj
1.0262 0 Td
(clinics)Tj
2.7552 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(endemic)Tj
3.651 0 Td
(areas,)Tj
2.4718 0 Td
(wider)Tj
2.4945 0 Td
(publicity,)Tj
3.9515 0 Td
(referral)Tj
3.1521 0 Td
(systems,)Tj
3.5206 0 Td
(inte-)Tj
-33.63 -1.2983 Td
(gration)Tj
3.1124 0 Td
(of)Tj
1.0148 0 Td
(MMDP)Tj
3.2995 0 Td
(into)Tj
1.8425 0 Td
(other)Tj
2.3471 0 Td
(disease)Tj
3.016 0 Td
(management)Tj
5.4368 0 Td
(services,)Tj
3.532 0 Td
(collaborations)Tj
5.879 0 Td
(with)Tj
1.9956 0 Td
(welfare)Tj
-31.4757 -1.2982 Td
(organizations)Tj
5.6409 0 Td
(and)Tj
1.7348 0 Td
(research)Tj
3.5546 0 Td
(groups)Tj
2.9707 0 Td
(were)Tj
2.1203 0 Td
(the)Tj
1.4683 0 Td
(opportunities)Tj
5.6296 0 Td
(identified.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 347.0173 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 330.0094 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(LF)Tj
1.2869 0 Td
(is)Tj
0.8447 0 Td
(an)Tj
1.2019 0 Td
(important)Tj
4.2859 0 Td
(public)Tj
2.7043 0 Td
(health)Tj
2.6815 0 Td
(and)Tj
1.7291 0 Td
(socioeconomic)Tj
6.2022 0 Td
(problem)Tj
3.6113 0 Td
(worldwide.)Tj
4.6885 0 Td
(It)Tj
0.8561 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.126 0 Td
(ranked)Tj
3.0217 0 Td
(as)Tj
-36.7821 -1.2982 Td
(the)Tj
1.4683 0 Td
(second)Tj
3.0104 0 Td
(leading)Tj
3.1351 0 Td
(cause)Tj
2.3867 0 Td
(of)Tj
1.0148 0 Td
(permanent)Tj
4.6034 0 Td
(disability)Tj
3.8551 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
1.5988 0 Td
(Of)Tj
1.2529 0 Td
(the)Tj
1.4683 0 Td
(disease)Tj
3.0217 0 Td
(manifestations)Tj
6.0718 0 Td
(associated)Tj
-32.8873 -1.3039 Td
(with)Tj
1.9955 0 Td
(LF,)Tj
1.5137 0 Td
(the)Tj
1.4684 0 Td
(most)Tj
2.2053 0 Td
(distressing)Tj
4.473 0 Td
(and)Tj
1.7292 0 Td
(disabling)Tj
3.8437 0 Td
(are)Tj
1.4513 0 Td
(lymphoedema,)Tj
6.1455 0 Td
(its)Tj
1.1452 0 Td
(advanced)Tj
3.9912 0 Td
(form)Tj
2.2053 0 Td
(elephantiasis,)Tj
-32.1673 -1.2983 Td
(hydrocele)Tj
4.1215 0 Td
(and)Tj
1.7348 0 Td
(acute)Tj
2.3244 0 Td
(inflammatory)Tj
5.7089 0 Td
(episodes)Tj
3.6057 0 Td
(termed)Tj
3.084 0 Td
(dermatolymphangioade)Tj
9.5584 0 Td
(nitis)Tj
1.9616 0 Td
(\(ADLA\))Tj
-32.0993 -1.2983 Td
(caused)Tj
2.9139 0 Td
(by)Tj
1.1849 0 Td
(secondary)Tj
4.269 0 Td
(infection)Tj
3.7927 0 Td
(of)Tj
1.0148 0 Td
(lymphoedematous)Tj
7.6138 0 Td
(tissues.)Tj
3.0444 0 Td
(Physical)Tj
3.4923 0 Td
(and)Tj
1.7348 0 Td
(social)Tj
2.4547 0 Td
(functions)Tj
3.9912 0 Td
(as)Tj
-35.5065 -1.3039 Td
(well)Tj
1.8198 0 Td
(as)Tj
1.0148 0 Td
(psychological)Tj
5.6012 0 Td
(wellbeing)Tj
4.0308 0 Td
(of)Tj
1.0148 0 Td
(patients)Tj
3.3676 0 Td
(with)Tj
1.9956 0 Td
(lymphoedema)Tj
5.9243 0 Td
(and)Tj
1.7292 0 Td
(elephantiasis)Tj
5.3291 0 Td
(are)Tj
1.4456 0 Td
(signifi-)Tj
-33.2728 -1.2982 Td
(cantly)Tj
2.6248 0 Td
(impaired)Tj
3.8494 0 Td
(due)Tj
1.6951 0 Td
(to)Tj
1.0262 0 Td
(the)Tj
1.4683 0 Td
(pain)Tj
1.9899 0 Td
(and)Tj
1.7292 0 Td
(discomfort,)Tj
4.8131 0 Td
(restricted)Tj
3.9855 0 Td
(mobility,)Tj
3.8154 0 Td
(social)Tj
2.4605 0 Td
(stigmatization,)Tj
6.1228 0 Td
(feel-)Tj
-35.5802 -1.2983 Td
(ings)Tj
1.8595 0 Td
(of)Tj
1.0148 0 Td
(embarrassment)Tj
6.3949 0 Td
(and)Tj
1.7291 0 Td
(emotional)Tj
4.269 0 Td
(distress)Tj
3.1917 0 Td
(that)Tj
1.7802 0 Td
(accompany)Tj
4.7792 0 Td
(these)Tj
2.2563 0 Td
(chronic)Tj
3.2882 0 Td
(disfiguring)Tj
-30.5629 -1.3039 Td
(manifestations)Tj
6.0717 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2643 0 Td
(3)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
0.9184 0 Td
(4)Tj
0 g
(].)Tj
1.2642 0 Td
(Those)Tj
2.6476 0 Td
(afflicted)Tj
3.4185 0 Td
(with)Tj
1.9956 0 Td
(advanced)Tj
3.9968 0 Td
(disease)Tj
3.0161 0 Td
(may)Tj
1.9275 0 Td
(lose)Tj
1.7575 0 Td
(their)Tj
2.109 0 Td
(livelihoods)Tj
4.5524 0 Td
(due)Tj
1.7007 0 Td
(to)Tj
-36.6403 -1.2983 Td
(the)Tj
1.4683 0 Td
(associated)Tj
4.2576 0 Td
(disability)Tj
3.8494 0 Td
(or)Tj
1.0999 0 Td
(social)Tj
2.4547 0 Td
(stigma)Tj
2.8687 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
1.5987 0 Td
(The)Tj
1.7858 0 Td
(ADLA)Tj
2.863 0 Td
(episodes)Tj
3.6057 0 Td
(are)Tj
1.4456 0 Td
(extremely)Tj
4.1499 0 Td
(painful)Tj
3.0501 0 Td
(and)Tj
-34.4974 -1.2983 Td
(incapacitating,)Tj
6.0717 0 Td
(incurring)Tj
4.0082 0 Td
(a)Tj
0.6576 0 Td
(significant)Tj
4.388 0 Td
(financial)Tj
3.6737 0 Td
(burden)Tj
3.1294 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.4684 0 Td
(form)Tj
2.211 0 Td
(of)Tj
1.0148 0 Td
(direct)Tj
2.5285 0 Td
(and)Tj
1.7291 0 Td
(indirect)Tj
-31.9122 -1.3039 Td
(costs)Tj
2.1713 0 Td
(attributed)Tj
4.1725 0 Td
(to)Tj
1.0262 0 Td
(medication)Tj
4.7338 0 Td
(and)Tj
1.7291 0 Td
(lost)Tj
1.6328 0 Td
(income)Tj
3.2088 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2642 0 Td
(7)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
0.9184 0 Td
(8)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
0.9241 0 Td
(9)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
0.9184 0 Td
(10)Tj
0 g
(].)Tj
1.7348 0 Td
(It)Tj
0.8618 0 Td
(is)Tj
0.8447 0 Td
(estimated)Tj
4.0762 0 Td
(that)Tj
1.7801 0 Td
(globally,)Tj
3.549 0 Td
(120)Tj
-35.5462 -1.2982 Td
(129)Tj
1.644 0 Td
(million)Tj
3.1238 0 Td
(people)Tj
2.8516 0 Td
(are)Tj
1.4514 0 Td
(infected)Tj
3.4185 0 Td
(with)Tj
2.0013 0 Td
(LF)Tj
1.2812 0 Td
(and)Tj
1.7348 0 Td
(of)Tj
1.0148 0 Td
(these,)Tj
2.4775 0 Td
(around)Tj
3.1351 0 Td
(40)Tj
1.1735 0 Td
(million)Tj
3.1181 0 Td
(have)Tj
2.0636 0 Td
(overt)Tj
2.2734 0 Td
(disease,)Tj
-32.7626 -1.2983 Td
(accounting)Tj
4.6601 0 Td
(for)Tj
1.3889 0 Td
(5.9)Tj
1.3947 0 Td
(million)Tj
3.1237 0 Td
(disability)Tj
3.8495 0 Td
(adjusted)Tj
3.5773 0 Td
(life)Tj
1.4456 0 Td
(years)Tj
2.2621 0 Td
(\(DALYs\),)Tj
4.0762 0 Td
(with)Tj
2.0012 0 Td
(a)Tj
0.652 0 Td
(concomitant)Tj
5.2951 0 Td
(loss)Tj
1.6951 0 Td
(of)Tj
-35.4215 -1.2983 Td
(productivity)Tj
5.1363 0 Td
(and)Tj
1.7291 0 Td
(social)Tj
2.4548 0 Td
(stigmatization)Tj
5.9017 0 Td
([)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
2.0749 0 Td
(Therefore,)Tj
4.3937 0 Td
(LF)Tj
1.2869 0 Td
(was)Tj
1.6952 0 Td
(identified)Tj
4.0591 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.6577 0 Td
(major)Tj
2.6078 0 Td
(public)Tj
-33.012 -1.3039 Td
(health)Tj
2.6758 0 Td
(problem)Tj
3.6114 0 Td
(and)Tj
1.7291 0 Td
(is)Tj
0.8504 0 Td
(targeted)Tj
3.4639 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.4683 0 Td
(World)Tj
2.8403 0 Td
(Health)Tj
2.914 0 Td
(Organization)Tj
5.5219 0 Td
(\(WHO\))Tj
3.3788 0 Td
(for)Tj
1.389 0 Td
(elimination)Tj
4.8472 0 Td
(by)Tj
-35.8693 -1.2982 Td
(2020.)Tj
1.1962 -1.2983 Td
(The)Tj
1.7858 0 Td
(Global)Tj
2.8743 0 Td
(Program)Tj
3.7474 0 Td
(for)Tj
1.3889 0 Td
(Eliminating)Tj
4.9493 0 Td
(LF)Tj
1.2869 0 Td
(\(GPELF\))Tj
3.8098 0 Td
(launched)Tj
3.8777 0 Td
(in)Tj
1.0375 0 Td
(year)Tj
1.8992 0 Td
(2000,)Tj
2.3527 0 Td
(consists)Tj
3.3449 0 Td
(of)Tj
1.0148 0 Td
(two)Tj
-34.5654 -1.3039 Td
(main)Tj
2.2903 0 Td
(components:)Tj
5.3972 0 Td
(MDA)Tj
2.5341 0 Td
(to)Tj
1.0262 0 Td
(stop)Tj
1.8992 0 Td
(the)Tj
1.474 0 Td
(spread)Tj
2.8516 0 Td
(of)Tj
1.0148 0 Td
(infection)Tj
3.7927 0 Td
(and)Tj
1.7291 0 Td
(MMDP)Tj
3.2996 0 Td
(to)Tj
1.0261 0 Td
(manage)Tj
3.3449 0 Td
(chronic)Tj
3.2881 0 Td
(dis-)Tj
-34.9679 -1.2983 Td
(ease.)Tj
2.0862 0 Td
(MDA)Tj
2.5342 0 Td
(for)Tj
1.3833 0 Td
(LF)Tj
1.2869 0 Td
(involves)Tj
3.4809 0 Td
(the)Tj
1.474 0 Td
(annual)Tj
2.9594 0 Td
(provision)Tj
4.0195 0 Td
(of)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(combined)Tj
4.2462 0 Td
(dose)Tj
2.0353 0 Td
(of)Tj
1.0148 0 Td
(medications)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 183.2882 23.6976 re
W* n
q
183.2315 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 316.4598 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(A)Tj
0.8787 0 Td
(SWOT)Tj
3.2032 0 Td
(analysis)Tj
3.763 0 Td
(of)Tj
1.0417 0 Td
(the)Tj
1.5804 0 Td
(lymphatic)Tj
4.3724 0 Td
(filariasis)Tj
3.756 0 Td
(morbidi)Tj
3.2102 0 Td
(ty)Tj
0.9922 0 Td
(alleviati)Tj
3.2527 0 Td
(on)Tj
1.3111 0 Td
(in)Tj
0.9779 0 Td
(Sri)Tj
1.4245 0 Td
(Lanka)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
163.5591 34.9228 m
317.7071 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(Neglected)Tj
4.6417 0 Td
(Tropical)Tj
3.7135 0 Td
(Disease)Tj
3.5433 0 Td
(s)Tj
0.7158 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8197 0 Td
(1/journal.pn)Tj
5.1237 0 Td
(td.00064)Tj
3.8197 0 Td
(72)Tj
0 g
2.0905 0 Td
(May)Tj
2.0835 0 Td
(10,)Tj
1.5874 0 Td
(2018)Tj
25.2569 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
26 0 obj
<>stream
endstream
endobj
27 0 obj
<>stream
endstream
endobj
28 0 obj
<>stream
endstream
endobj
29 0 obj
<>stream
endstream
endobj
30 0 obj
<>stream
endstream
endobj
31 0 obj
<>stream
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
BT
66.402 0 Td
(11)Tj
ET
Q
endstream
endobj
38 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 9 0 R/Annots 40 0 R/Contents 41 0 R/TrimBox[0 0 612 792]>>
endobj
40 0 obj
[42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R]
endobj
42 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref012)>>
endobj
43 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref013)>>
endobj
44 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref014)>>
endobj
45 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref014)>>
endobj
46 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref015)>>
endobj
47 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.g001)>>
endobj
48 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref016)>>
endobj
49 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref017)>>
endobj
50 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref018)>>
endobj
51 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006472.ref018)>>
endobj
52 0 obj
<>/Border[0 0 0]/A 53 0 R>>
endobj
53 0 obj
<>
endobj
41 0 obj
[54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R]
endobj
54 0 obj
<>stream
q
0.83 0.64 0.02 0 k
233.5748 654.3496 m
243.0992 654.3496 l
h
f*
232.0441 576.3402 m
241.5685 576.3402 l
h
f*
336.189 537.3354 m
345.7134 537.3354 l
h
f*
332.674 511.3134 m
342.1984 511.3134 l
h
f*
330.8598 498.3307 m
340.3843 498.3307 l
h
f*
509.1024 426.6142 m
528.6614 426.6142 l
h
f*
484.6677 400.6488 m
494.1921 400.6488 l
h
f*
266.2866 335.622 m
275.811 335.622 l
h
f*
203.3575 257.6126 m
212.7685 257.6126 l
h
f*
547.0299 231.6472 m
556.4409 231.6472 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 200.0125 707.4141 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
({diethylcarbamazine)Tj
8.3791 0 Td
(citrate)Tj
2.7383 0 Td
(\(DEC\))Tj
2.8686 0 Td
(+)Tj
0.7994 0 Td
(albendazole)Tj
4.9322 0 Td
(\(old)Tj
1.8369 0 Td
(regimen\))Tj
3.8834 0 Td
(+)Tj
0.7994 0 Td
(ivermectin)Tj
4.5127 0 Td
(\(new)Tj
2.2167 0 Td
(triple)Tj
2.347 0 Td
(ther-)Tj
-35.3137 -1.3039 Td
(apy\))Tj
1.9672 0 Td
(or)Tj
1.0941 0 Td
(in)Tj
1.0375 0 Td
(areas)Tj
2.245 0 Td
(co-endemic)Tj
4.9323 0 Td
(for)Tj
1.389 0 Td
(onchocerciasis,)Tj
6.2872 0 Td
(ivermectin)Tj
4.5184 0 Td
(+)Tj
0.7993 0 Td
(albendazole})Tj
5.2724 0 Td
(to)Tj
1.0262 0 Td
(all)Tj
1.1452 0 Td
(eligible)Tj
3.067 0 Td
(per-)Tj
-34.7808 -1.2982 Td
(sons)Tj
1.9955 0 Td
(living)Tj
2.4718 0 Td
(in)Tj
1.0318 0 Td
(an)Tj
1.2019 0 Td
(endemic)Tj
3.6567 0 Td
(area,)Tj
2.1089 0 Td
(for)Tj
1.3833 0 Td
(at)Tj
0.9525 0 Td
(least)Tj
1.9842 0 Td
(5)Tj
0.6973 0 Td
(years.)Tj
2.4888 0 Td
(MMDP)Tj
3.2995 0 Td
(involves)Tj
3.481 0 Td
(a)Tj
0.6576 0 Td
(basic)Tj
2.211 0 Td
(package)Tj
3.4129 0 Td
(of)Tj
-33.0347 -1.2983 Td
(recommended)Tj
6.032 0 Td
(health-care)Tj
4.6828 0 Td
(services)Tj
3.3052 0 Td
(to)Tj
1.0262 0 Td
(alleviate)Tj
3.4469 0 Td
(suffering)Tj
3.7587 0 Td
(and)Tj
1.7291 0 Td
(prevent)Tj
3.2598 0 Td
(further)Tj
3.0274 0 Td
(progression)Tj
4.9209 0 Td
(of)Tj
-35.189 -1.2983 Td
(disease)Tj
3.016 0 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(].)Tj
2.0749 0 Td
(The)Tj
1.7859 0 Td
(minimum)Tj
4.2859 0 Td
(recommended)Tj
6.0378 0 Td
(package)Tj
3.4129 0 Td
(for)Tj
1.3889 0 Td
(MMDP)Tj
3.2995 0 Td
(includes)Tj
3.5433 0 Td
(i\))Tj
0.8277 0 Td
(MDA,)Tj
2.761 0 Td
(which)Tj
2.6475 0 Td
(in)Tj
-35.0813 -1.3039 Td
(addition)Tj
3.5943 0 Td
(to)Tj
1.0261 0 Td
(reducing)Tj
3.7757 0 Td
(microfilariaemia)Tj
6.8598 0 Td
(below)Tj
2.5909 0 Td
(a)Tj
0.6519 0 Td
(target)Tj
2.5115 0 Td
(threshold)Tj
4.0082 0 Td
(at)Tj
0.9524 0 Td
(which)Tj
2.6532 0 Td
(transmission)Tj
5.3631 0 Td
(is)Tj
0.8448 0 Td
(con-)Tj
-34.8319 -1.2982 Td
(sidered)Tj
3.118 0 Td
(non-sustainable,)Tj
6.8088 0 Td
(may)Tj
1.9276 0 Td
(also)Tj
1.7688 0 Td
(destroy)Tj
3.1634 0 Td
(invading)Tj
3.7361 0 Td
(larvae)Tj
2.5851 0 Td
(\(L3\))Tj
1.9106 0 Td
(or)Tj
1.0998 0 Td
(juvenile)Tj
3.3675 0 Td
(worms)Tj
2.9651 0 Td
(in)Tj
1.0318 0 Td
(those)Tj
-33.4826 -1.2983 Td
(with)Tj
1.9955 0 Td
(recently)Tj
3.4129 0 Td
(acquired)Tj
3.6964 0 Td
(infections,)Tj
4.3823 0 Td
(or)Tj
1.0942 0 Td
(selective)Tj
3.5433 0 Td
(treatment)Tj
4.1385 0 Td
(of)Tj
1.0148 0 Td
(individuals)Tj
4.6488 0 Td
(positive)Tj
3.3165 0 Td
(for)Tj
1.3833 0 Td
(infection)Tj
-32.6265 -1.3039 Td
(with)Tj
1.9955 0 Td
(a)Tj
0.652 0 Td
(prolonged)Tj
4.337 0 Td
(regimen)Tj
3.5376 0 Td
(of)Tj
1.0148 0 Td
(DEC)Tj
2.1883 0 Td
(to)Tj
1.0262 0 Td
(destroy)Tj
3.1634 0 Td
(any)Tj
1.6554 0 Td
(remaining)Tj
4.3653 0 Td
(adult)Tj
2.2564 0 Td
(parasites)Tj
3.685 0 Td
(or)Tj
1.0999 0 Td
(microfilaria;)Tj
5.142 0 Td
(ii\))Tj
-36.1188 -1.2983 Td
(surgery)Tj
3.1917 0 Td
(for)Tj
1.389 0 Td
(hydrocele;)Tj
4.3483 0 Td
(iii\))Tj
1.3606 0 Td
(treatment)Tj
4.1386 0 Td
(of)Tj
1.0148 0 Td
(ADLA;)Tj
3.0897 0 Td
(iv\))Tj
1.2813 0 Td
(prevent)Tj
3.2542 0 Td
(progression)Tj
4.9209 0 Td
(of)Tj
1.0148 0 Td
(lymphoedema)Tj
5.9243 0 Td
(and)Tj
-34.9282 -1.2983 Td
(ADLA)Tj
2.8629 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(].)Tj
-1.6667 -1.3039 Td
(Considerable)Tj
5.5048 0 Td
(progress)Tj
3.5943 0 Td
(has)Tj
1.5421 0 Td
(been)Tj
2.1259 0 Td
(made)Tj
2.4208 0 Td
(with)Tj
2.0012 0 Td
(regard)Tj
2.812 0 Td
(to)Tj
1.0261 0 Td
(MDA.)Tj
2.7553 0 Td
(Of)Tj
1.2586 0 Td
(73)Tj
1.1678 0 Td
(countries)Tj
3.9515 0 Td
(considered)Tj
4.5978 0 Td
(to)Tj
-35.9544 -1.2982 Td
(be)Tj
1.1508 0 Td
(endemic)Tj
3.651 0 Td
(in)Tj
1.0375 0 Td
(2014,)Tj
2.3471 0 Td
(20)Tj
1.1735 0 Td
(had)Tj
1.7064 0 Td
(progressed)Tj
4.5468 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.474 0 Td
(post-MDA)Tj
4.5638 0 Td
(surveillance)Tj
4.9492 0 Td
(phase)Tj
2.4832 0 Td
(by)Tj
1.1792 0 Td
(2016)Tj
2.1259 0 Td
(and)Tj
1.7292 0 Td
(52)Tj
-35.1437 -1.2983 Td
(required)Tj
3.6396 0 Td
(further)Tj
3.0274 0 Td
(rounds)Tj
3.0614 0 Td
(of)Tj
1.0148 0 Td
(MDA)Tj
2.5341 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(].)Tj
2.075 0 Td
(However,)Tj
4.0762 0 Td
(unlike)Tj
2.7326 0 Td
(MDA,)Tj
2.7552 0 Td
(only)Tj
1.9786 0 Td
(34)Tj
1.1735 0 Td
(endemic)Tj
3.651 0 Td
(countries)Tj
3.9515 0 Td
(have)Tj
-35.6709 -1.3039 Td
(initiated)Tj
3.5489 0 Td
(MMDP)Tj
3.2995 0 Td
(services)Tj
3.3109 0 Td
(and)Tj
1.7291 0 Td
(there)Tj
2.262 0 Td
(is)Tj
0.8504 0 Td
(evidence)Tj
3.7134 0 Td
(that)Tj
1.7744 0 Td
(coverage)Tj
3.7247 0 Td
(is)Tj
0.8448 0 Td
(being)Tj
2.4321 0 Td
(monitored)Tj
4.49 0 Td
(by)Tj
1.1849 0 Td
(implemen-)Tj
-33.1651 -1.2983 Td
(tation)Tj
2.5738 0 Td
(units)Tj
2.2223 0 Td
(in)Tj
1.0318 0 Td
(only)Tj
1.9786 0 Td
(25)Tj
1.1736 0 Td
(countries)Tj
3.9458 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(].)Tj
2.0749 0 Td
(Therefore,)Tj
4.3937 0 Td
(implementation)Tj
6.6387 0 Td
(of)Tj
1.0148 0 Td
(MMDP)Tj
3.2995 0 Td
(appears)Tj
3.2825 0 Td
(to)Tj
1.0204 0 Td
(be)Tj
1.1509 0 Td
(far)Tj
-35.8013 -1.2982 Td
(behind)Tj
3.0217 0 Td
(MDA)Tj
2.5341 0 Td
(in)Tj
1.0318 0 Td
(most)Tj
2.2054 0 Td
(countries)Tj
3.9514 0 Td
([)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(].)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 470.7212 cm
BT
/F10 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(LF)Tj
1.3133 0 Td
(in)Tj
1.0678 0 Td
(Sri)Tj
1.4079 0 Td
(Lanka)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 453.7133 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(A)Tj
0.9014 0 Td
(total)Tj
2.0069 0 Td
(of)Tj
1.0148 0 Td
(eight)Tj
2.1996 0 Td
(districts)Tj
3.3959 0 Td
(\(Colombo,)Tj
4.5411 0 Td
(Gampaha,)Tj
4.3313 0 Td
(Kalutara,)Tj
3.8608 0 Td
(Galle,)Tj
2.5115 0 Td
(Matara,)Tj
3.3108 0 Td
(Hambantota,)Tj
5.4935 0 Td
(Puttalam)Tj
-33.5676 -1.3039 Td
(and)Tj
1.7291 0 Td
(Kurunegala\))Tj
5.21 0 Td
(belonging)Tj
4.2009 0 Td
(to)Tj
1.0262 0 Td
(three)Tj
2.262 0 Td
(provinces)Tj
4.0932 0 Td
(\(Western,)Tj
4.1782 0 Td
(Southern)Tj
3.9005 0 Td
(and)Tj
1.7291 0 Td
(North)Tj
2.6646 0 Td
(Western\))Tj
3.9514 0 Td
(in)Tj
1.0318 0 Td
(Sri)Tj
-35.977 -1.2982 Td
(Lanka)Tj
2.6702 0 Td
(were)Tj
2.1203 0 Td
(identified)Tj
4.0592 0 Td
(as)Tj
1.0148 0 Td
(endemic)Tj
3.6566 0 Td
(for)Tj
1.3833 0 Td
(LF)Tj
1.2869 0 Td
(during)Tj
2.9254 0 Td
(the)Tj
1.474 0 Td
(elimination)Tj
4.8472 0 Td
(program)Tj
3.702 0 Td
(\(see)Tj
0.83 0.64 0.02 0 k
1.7688 0 Td
(Fig)Tj
1.4797 0 Td
(1)Tj
0 g
(\).)Tj
1.2643 0 Td
(Post-)Tj
-33.6527 -1.2983 Td
(MDA)Tj
2.5341 0 Td
(surveillance)Tj
4.9436 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(endemic)Tj
3.6567 0 Td
(region)Tj
2.8006 0 Td
(revealed)Tj
3.5263 0 Td
(low-level)Tj
3.7984 0 Td
(persistence)Tj
4.6431 0 Td
(of)Tj
1.0148 0 Td
(bancroftian)Tj
4.8415 0 Td
(filariasis)Tj
-34.2649 -1.2983 Td
(in)Tj
1.0318 0 Td
(a)Tj
0.6576 0 Td
(few)Tj
1.6157 0 Td
(areas)Tj
2.2451 0 Td
(and)Tj
1.7291 0 Td
(re-emergence)Tj
5.6862 0 Td
(of)Tj
1.0148 0 Td
(brugian)Tj
3.3392 0 Td
(filariasis)Tj
3.5206 0 Td
(after)Tj
2.0353 0 Td
(four)Tj
1.9105 0 Td
(decades)Tj
3.3392 0 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(],)Tj
2.0806 0 Td
(both)Tj
2.058 0 Td
(of)Tj
1.0148 0 Td
(which)Tj
-33.2785 -1.3039 Td
(require)Tj
3.1124 0 Td
(continued)Tj
4.2916 0 Td
(individual)Tj
4.286 0 Td
(treatment.)Tj
-10.4938 -1.2982 Td
(Reduction)Tj
4.3653 0 Td
(of)Tj
1.0148 0 Td
(microfilaria)Tj
4.9209 0 Td
(rates)Tj
2.1033 0 Td
(below)Tj
2.5908 0 Td
(the)Tj
1.4684 0 Td
(target)Tj
2.5115 0 Td
(threshold)Tj
4.0081 0 Td
(of)Tj
1.0148 0 Td
(1%,)Tj
1.6781 0 Td
(following)Tj
3.9798 0 Td
(five)Tj
1.6555 0 Td
(successful)Tj
-32.5075 -1.2983 Td
(rounds)Tj
3.0613 0 Td
(of)Tj
1.0148 0 Td
(MDA)Tj
2.5342 0 Td
(\(DEC)Tj
2.5285 0 Td
(+)Tj
0.7994 0 Td
(albendazole\),)Tj
5.4991 0 Td
(enabled)Tj
3.3279 0 Td
(the)Tj
1.4683 0 Td
(submission)Tj
4.7509 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(elimination)Tj
4.8472 0 Td
(dossier)Tj
3.0387 0 Td
(in)Tj
-35.3534 -1.3039 Td
(2015.)Tj
2.347 0 Td
(In)Tj
1.1055 0 Td
(2016,)Tj
2.3528 0 Td
(Sri)Tj
1.3322 0 Td
(Lanka)Tj
2.6703 0 Td
(received)Tj
3.5376 0 Td
(validation)Tj
4.2009 0 Td
(from)Tj
2.2053 0 Td
(WHO)Tj
2.7043 0 Td
(of)Tj
1.0148 0 Td
(having)Tj
2.914 0 Td
(eliminated)Tj
4.4787 0 Td
(LF)Tj
1.2812 0 Td
(as)Tj
1.0205 0 Td
(a)Tj
0.652 0 Td
(public)Tj
-33.8171 -1.2983 Td
(health)Tj
2.6758 0 Td
(problem)Tj
3.6114 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(].)Tj
2.0749 0 Td
(Given)Tj
2.6305 0 Td
(the)Tj
1.474 0 Td
(high)Tj
2.007 0 Td
(profile)Tj
2.8403 0 Td
(efforts)Tj
2.7552 0 Td
(required)Tj
3.6397 0 Td
(to)Tj
1.0261 0 Td
(interrupt)Tj
3.8438 0 Td
(transmission,)Tj
5.5899 0 Td
(morbid-)Tj
-34.1686 -1.2983 Td
(ity)Tj
1.2415 0 Td
(management)Tj
5.4312 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.126 0 Td
(given)Tj
2.3754 0 Td
(rather)Tj
2.6475 0 Td
(lower)Tj
2.4548 0 Td
(priority.)Tj
-0.008 Tc
-16.6222 -1.3039 Td
(The)Tj
1.7744 0 Td
(current)Tj
3.1521 0 Td
(status)Tj
2.4775 0 Td
(of)Tj
1.0091 0 Td
(the)Tj
1.457 0 Td
(MMDP)Tj
3.2825 0 Td
(program)Tj
3.6794 0 Td
(was)Tj
1.6894 0 Td
(assessed)Tj
3.4413 0 Td
(using)Tj
2.364 0 Td
(the)Tj
1.4627 0 Td
(SWOT)Tj
2.999 0 Td
(analysis)Tj
3.2939 0 Td
(tool,)Tj
-33.2785 -1.2982 Td
(within)Tj
2.7836 0 Td
(the)Tj
1.4513 0 Td
(context)Tj
3.1464 0 Td
(of)Tj
1.0035 0 Td
(recent)Tj
2.6759 0 Td
(validation)Tj
4.1612 0 Td
(of)Tj
0.9978 0 Td
(LF)Tj
1.2756 0 Td
(elimination)Tj
4.7962 0 Td
(in)Tj
1.0204 0 Td
(Sri)Tj
1.3153 0 Td
(Lanka.)Tj
2.8686 0 Td
(SWOT)Tj
2.9934 0 Td
(analysis)Tj
3.2882 0 Td
(is)Tj
0.8334 0 Td
(defined)Tj
-34.6108 -1.2983 Td
(as)Tj
1.0034 0 Td
(an)Tj
1.1962 0 Td
(examination)Tj
5.1874 0 Td
(of)Tj
1.0091 0 Td
(an)Tj
1.1962 0 Td
(organization's)Tj
5.7997 0 Td
(internal)Tj
3.3278 0 Td
(strengths)Tj
3.8381 0 Td
(and)Tj
1.7178 0 Td
(weaknesses,)Tj
4.9152 0 Td
(the)Tj
1.457 0 Td
(opportunities)Tj
5.5843 0 Td
(for)Tj
-36.2322 -1.3039 Td
(growth)Tj
3.05 0 Td
(and)Tj
1.7178 0 Td
(improvement,)Tj
5.845 0 Td
(and)Tj
1.7178 0 Td
(the)Tj
1.4626 0 Td
(threats)Tj
2.9027 0 Td
(posed)Tj
2.5398 0 Td
(by)Tj
1.1736 0 Td
(the)Tj
1.457 0 Td
(external)Tj
3.3959 0 Td
(environment)Tj
5.3857 0 Td
(to)Tj
1.0205 0 Td
(its)Tj
1.1339 0 Td
(survival)Tj
-32.8023 -1.2983 Td
([)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
2.0579 0 Td
(This)Tj
1.9672 0 Td
(process)Tj
3.1578 0 Td
(was)Tj
1.6894 0 Td
(originally)Tj
3.9855 0 Td
(designed)Tj
3.7304 0 Td
(for)Tj
1.3776 0 Td
(use)Tj
1.5194 0 Td
(in)Tj
1.0261 0 Td
(the)Tj
1.457 0 Td
(corporate)Tj
4.0365 0 Td
(sector)Tj
2.5795 0 Td
(and)Tj
1.7235 0 Td
(although)Tj
3.719 0 Td
(novel,)Tj
2.6022 0 Td
(is)Tj
-36.629 -1.2982 Td
(gaining)Tj
3.1861 0 Td
(recognition)Tj
4.8018 0 Td
(for)Tj
1.3777 0 Td
(use)Tj
1.5193 0 Td
(in)Tj
1.0262 0 Td
(healthcare.)Tj
4.5127 0 Td
(Ideally)Tj
2.863 0 Td
(SWOT)Tj
3.0047 0 Td
(analysis)Tj
3.2938 0 Td
(includes)Tj
3.5149 0 Td
(a)Tj
0.6463 0 Td
(comprehensive)Tj
-29.7465 -1.2983 Td
(review)Tj
2.8176 0 Td
(of)Tj
1.0091 0 Td
(healthcare)Tj
4.2916 0 Td
(literature,)Tj
4.0592 0 Td
(in-depth)Tj
3.651 0 Td
(data)Tj
1.8992 0 Td
(analysis)Tj
3.2938 0 Td
(and)Tj
1.7178 0 Td
(input)Tj
2.3584 0 Td
(from)Tj
2.1884 0 Td
(a)Tj
0.6519 0 Td
(panel)Tj
2.3698 0 Td
(of)Tj
1.0034 0 Td
(experts)Tj
3.0558 0 Td
([)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
-34.367 -1.3039 Td
(Findings)Tj
3.702 0 Td
(from)Tj
2.1883 0 Td
(the)Tj
1.457 0 Td
(analysis)Tj
3.2938 0 Td
(are)Tj
1.44 0 Td
(sorted)Tj
2.6816 0 Td
(into)Tj
1.8255 0 Td
(four)Tj
1.8992 0 Td
(broad)Tj
2.5455 0 Td
(categories;)Tj
4.3767 0 Td
(strengths,)Tj
4.0591 0 Td
(weaknesses,)Tj
4.921 0 Td
(oppor-)Tj
-34.3897 -1.2983 Td
(tunities)Tj
3.1804 0 Td
(and)Tj
1.7178 0 Td
(threats.)Tj
3.1237 0 Td
(This)Tj
1.9729 0 Td
(tool)Tj
1.7632 0 Td
(provides)Tj
3.617 0 Td
(a)Tj
0.6519 0 Td
(framework)Tj
4.5751 0 Td
(for)Tj
1.3777 0 Td
(reviewing)Tj
4.0875 0 Td
(the)Tj
1.457 0 Td
(program)Tj
3.6793 0 Td
(in)Tj
1.0262 0 Td
(an)Tj
1.1962 0 Td
(inter-dis-)Tj
-33.4259 -1.2983 Td
(ciplinary)Tj
3.7133 0 Td
(manner)Tj
3.3392 0 Td
(and)Tj
1.7178 0 Td
(brings)Tj
2.7156 0 Td
(the)Tj
1.4626 0 Td
(organization)Tj
5.2328 0 Td
(into)Tj
1.8255 0 Td
(balance)Tj
3.2088 0 Td
(with)Tj
1.9785 0 Td
(the)Tj
1.457 0 Td
(external)Tj
3.4016 0 Td
(environment)Tj
5.3858 0 Td
(and)Tj
-35.4385 -1.3039 Td
(maintains)Tj
4.1612 0 Td
(that)Tj
1.7631 0 Td
(balance)Tj
3.2088 0 Td
(over)Tj
1.9616 0 Td
(time.)Tj
2.2337 0 Td
(The)Tj
1.7688 0 Td
(goal)Tj
1.8538 0 Td
(of)Tj
1.0092 0 Td
(the)Tj
1.457 0 Td
(SWOT)Tj
3.0047 0 Td
(analysis)Tj
3.2938 0 Td
(was)Tj
1.6838 0 Td
(to)Tj
1.0204 0 Td
(evaluate)Tj
3.4299 0 Td
(the)Tj
1.457 0 Td
(MMDP)Tj
-33.3068 -1.2982 Td
(program)Tj
3.6736 0 Td
(and)Tj
1.7235 0 Td
(services)Tj
3.2711 0 Td
(with)Tj
1.9843 0 Td
(the)Tj
1.457 0 Td
(intent)Tj
2.5795 0 Td
(of)Tj
1.0034 0 Td
(providing)Tj
4.1103 0 Td
(recommendations)Tj
7.4437 0 Td
(for)Tj
1.372 0 Td
(maximizing)Tj
4.9492 0 Td
(organiza-)Tj
-33.5676 -1.2983 Td
(tional)Tj
2.4944 0 Td
(performance)Tj
5.3064 0 Td
(with)Tj
1.9786 0 Td
(the)Tj
1.457 0 Td
(limited)Tj
3.0444 0 Td
(resources)Tj
3.9515 0 Td
(available)Tj
3.634 0 Td
(for)Tj
1.3719 0 Td
(achieving)Tj
3.9969 0 Td
(the)Tj
1.457 0 Td
(goals)Tj
2.211 0 Td
(of)Tj
1.0091 0 Td
(the)Tj
1.457 0 Td
(MMDP)Tj
-33.3692 -1.3039 Td
(program,)Tj
3.9004 0 Td
(i.e.,)Tj
1.5647 0 Td
(to)Tj
1.0148 0 Td
(provide)Tj
3.2598 0 Td
(access)Tj
2.6249 0 Td
(to)Tj
1.0148 0 Td
(basic)Tj
2.194 0 Td
(care)Tj
1.8595 0 Td
(for)Tj
1.372 0 Td
(all)Tj
1.1338 0 Td
(affected)Tj
3.2939 0 Td
(by)Tj
1.1735 0 Td
(lymphatic)Tj
4.1726 0 Td
(filarial)Tj
2.7439 0 Td
(disease.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 112.9889 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Methods)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 95.9811 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(In)Tj
1.1055 0 Td
(order)Tj
2.4207 0 Td
(to)Tj
1.0262 0 Td
(identify)Tj
3.2938 0 Td
(the)Tj
1.474 0 Td
(strengths)Tj
3.8721 0 Td
(and)Tj
1.7291 0 Td
(weaknesses)Tj
4.7395 0 Td
(within)Tj
2.812 0 Td
(the)Tj
1.4683 0 Td
(MMDP)Tj
3.2995 0 Td
(program)Tj
3.7077 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.474 0 Td
(oppor-)Tj
-34.1515 -1.2982 Td
(tunities)Tj
3.2087 0 Td
(and)Tj
1.7292 0 Td
(threats)Tj
2.9366 0 Td
(from)Tj
2.2054 0 Td
(outside)Tj
3.1351 0 Td
(the)Tj
1.4683 0 Td
(AFC)Tj
2.092 0 Td
(and)Tj
1.7348 0 Td
(its)Tj
1.1452 0 Td
(MMDP)Tj
3.2995 0 Td
(program,)Tj
3.9288 0 Td
(a)Tj
0.6576 0 Td
(situation)Tj
3.7304 0 Td
(analysis)Tj
3.3221 0 Td
(was)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 183.2882 23.6976 re
W* n
q
183.2315 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 316.4598 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(A)Tj
0.8787 0 Td
(SWOT)Tj
3.2032 0 Td
(analysis)Tj
3.763 0 Td
(of)Tj
1.0417 0 Td
(the)Tj
1.5804 0 Td
(lymphatic)Tj
4.3724 0 Td
(filariasis)Tj
3.756 0 Td
(morbidi)Tj
3.2102 0 Td
(ty)Tj
0.9922 0 Td
(alleviati)Tj
3.2527 0 Td
(on)Tj
1.3111 0 Td
(in)Tj
0.9779 0 Td
(Sri)Tj
1.4245 0 Td
(Lanka)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
163.5591 34.9228 m
317.7071 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(Neglected)Tj
4.6417 0 Td
(Tropical)Tj
3.7135 0 Td
(Disease)Tj
3.5433 0 Td
(s)Tj
0.7158 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8197 0 Td
(1/journal.pn)Tj
5.1237 0 Td
(td.00064)Tj
3.8197 0 Td
(72)Tj
0 g
2.0905 0 Td
(May)Tj
2.0835 0 Td
(10,)Tj
1.5874 0 Td
(2018)Tj
25.2569 0 Td
(3)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
55 0 obj
<>stream
endstream
endobj
56 0 obj
<>stream
endstream
endobj
57 0 obj
<>stream
endstream
endobj
58 0 obj
<>stream
endstream
endobj
59 0 obj
<>stream
endstream
endobj
60 0 obj
<>stream
endstream
endobj
61 0 obj
<>stream
endstream
endobj
62 0 obj
<>stream
endstream
endobj
63 0 obj
<>stream
endstream
endobj
64 0 obj
<>stream
BT
66.402 0 Td
(11)Tj
ET
Q
endstream
endobj
65 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 9 0 R/Annots 68 0 R/Contents 69 0 R/TrimBox[0 0 612 792]>>
endobj
67 0 obj
<>stream
xgօB@w۸OMvq#A۸㌻🞆d$2駞{:ugE$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@$@3%YYٹ9y5
mcc@yiVǔWu/ltnFFfumk
\Hrum+7xj%yiqp|.xh*h˿nfd8էǶ5l<0Л1:JaEIHHHHHHH.@a^+<2ʯlhcC:9R%[r5^&N'wt5멊?k=bHHHHHHHHH`josnZrˬٳn>mыx{Zod9s.(&v=,^<{6TN=46֥7CaӾap M [/=-pOy-XC=SRLX?^Y8wwQJ%s *~Z#=̃P;oc#Su<*\H$@$@$@$@$@$@$@$@W@T|o}?{sŞyҦ)z1:ntxnnECÃ]@"jbX42t`[{[W%3#@nBHhmԈmaVe]Ejm3=ʓ-p H`ܩًl;o]rY'^kuVᢅ=tYnPTh:)yj[v>.ha휔Q[dGkChGeme{hZĥ
]؋}??ybvN'7ne#a1[owG[r\{7oyBR=̒=iIv[wؼe#&a1-]zA;;"B套.Y8wphe]WWx()oݾc}ں~A
بP'ҁ6/M۶n-vNߓ 4 r*ԬYמ{#;46Q4ʥ߮kf}˒)EGnGn$6wy-펻y]UC_]鱾>hnnU//]XLlyz3/``U1ZVTm6~ {M7͙#MG69[Zs!{}˗-?if7XW](yg;| -_qC?_BK~Frs{.Mn^|]w=Sfn#06Zy75we/l əhl){#}O=4;pl ؇?)-+݇-$?ϟ?>,p6V\|ӂIϕh`9D>S>cƠ\>e!+S"ܟYy `mϾ{o_Uc9asp8ҧ)w|+{}ᅇ_Vlfs*+O,Z8|g86_x'A3GneMyg{ቧe-%{TthsZbKb-<ɜ%+f*Rfo{͟z^sMj s*8'}t1{*EƆ}ڋ>~OQUq^|Ll-\wkm\ %MȨG[֮͛X.!}yZscuk|ؼ/) I
}J|ZaYb>f}xl|tlƧ~s.pϚ5yeBJ-E5=g;J%>)TȬwHc ӝ=C%y }μ%(7ҍ7R-Z&g608d*>ITKqٽ{% <<4X+_z;>=G/o8ΚjE2fsc̝5{O;N?.*67~k巉k5v=+p~Sb/wSc5%?~>>hс=V;T7qa?敘9llpp %.֥B-vmS={ܣ8~9}rp'qhh47ˏMzNj9n=S*(2:228Z-IHHHHHHH.'zFj
/;~-1f`C/PTK_$Qq%CRR)g*jAzW2I#Oar9ޤuνâXiz="NJ2ѐM'O\_0m%%ŠP62oVٺ/6%hdMC9!Ԏ͟3뮇uJ>0osJtV=~̪BrL鳏ދbcɸ ҕ=%Z3$@$@$@$@$@$@$@$@$pLϟ7gN(^z4O[{ƳFTHlcpÍHOwOyiyDx^+o&Sßp6ƿW=!ӷKSEű '[☚SThf|\_;XހAuܿ<pa'{ZFRHooй:+GG*Rm,~ILjQS!>;+{ճ-5p?Y-'@og,Պv &uͰՍ%wb7-v\SlANK9g-d
U.E,rvQА߾mW_|/yHWWM|Yb*w--jiLm|yKr-b=6-7疕"'4X'o/sJa١OExҙ +^jA]SK^^q~7߹w彋 3Ὴ1EţBQqltpY$ԍG!3hkm{9-s! LI`Xԁuj?{Vou/6a\{3+L)*:[|K./PE9KT̈yf-]Z߹w*%,甒?=]mw?w>:TQ𬊳E;Vo_疄Kuf ?~c,喅tҘ`
#6s!*35}beo3 QPF *vyE< \C:QV'^Hm7ELL_o#CV~K' Uo8k`S/1ѩsZBFߡo
QqAoysoWJRbog]k̝}:D%N)*6mtw~H.l 䀿K_z?~𰪂o7Ofb㢢DŃ;ף5HHHHHHHHHOPTDp;Wܲ`ݧJrcs-/+˝$*'Y<[OA@7n36qII--?{{ݷ''8SF2mf^r#VG,/Y8oъUmC2 &G